Morton Neuroma and Forefoot Pain — assessment and management in Brisbane
Morton neuroma and intermetatarsal bursitis can cause forefoot pain, burning, tingling or a pebble-like sensation under the ball of the foot. Symptoms are often worse in tight shoes or with prolonged walking.

Morton neuroma describes irritation and thickening around a nerve between the metatarsal bones in the forefoot. Intermetatarsal bursitis can produce similar symptoms and may coexist. Patients often describe burning, tingling, numbness or a feeling of walking on a small pebble.

Assessment considers footwear, foot shape, activity load, tenderness between the metatarsals and whether symptoms are nerve-like. Ultrasound can be useful when the diagnosis is uncertain or an image-guided procedure is being planned.

Non-surgical care usually begins with reducing compression through the forefoot. This may involve wider shoes, metatarsal support, load modification and addressing training or work demands. Persistent symptoms may warrant discussion of injection options and, in selected cases, surgical referral.

Common symptoms

  • Burning, tingling or numbness into the toes
  • Pain under the ball of the foot
  • Feeling like there is a pebble or fold in the sock
  • Symptoms worse in narrow shoes, heels or prolonged walking

Commonly seen in

Every treatment reviewed for this diagnosis

Evidence for twelve treatment options in morton neuroma and forefoot pain

This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.

Foundation — diagnosis, education and rehabilitation

The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.

Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care

What it involves

Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.

What the evidence shows

Conservative care comes first, and it holds up well. A network meta-analysis of 49 randomised trials and 3,323 patients with carpal tunnel syndrome ranked manual therapy first for both short- and medium-term pain relief, ahead of every injection option including corticosteroid (Chen, Arch Phys Med Rehabil 2025).

Pairing reviewed 2026-09-02.

Where it fits for you

Load management, splinting where it fits, and addressing what is irritating the nerve come before any injection. Where the nerve is being compressed structurally and function is being lost, surgical review is the right conversation rather than more conservative care.

Muscle and symptom-modifying options

Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.

Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant

What it involves

The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.

What the evidence shows

Trigger-point injection reviews address confirmed myofascial pain and find heterogeneous, generally low-certainty results; they do not establish the technique as treatment for the underlying diagnosis. Condition reviewed: morton neuroma.

Evidence source: Debrosse et al., trigger-point injection systematic review (2022)

Pairing reviewed 2026-08-30.

Where it fits for you

For morton neuroma, this may be considered only when examination finds a separate tender muscle band reproducing part of the pain. It does not treat the primary pathology and is used to help movement or rehabilitation.

Read more about wet needling and trigger point injection
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Good support

What it involves

The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.

What the evidence shows

This is one of the few places where ultrasound guidance was compared head to head with an unguided injection. In an evaluator-blinded randomised trial, 33 people had landmark-guided corticosteroid injection and 38 had it under ultrasound; pain improvement favoured the guided group out to three years, and satisfaction at three years was 87 per cent against 59 per cent (Santiago, Eur Radiol 2022). A systematic review of ten studies in 695 people found a moderate short- to medium-term benefit over usual care with a low rate of adverse events, though it rated study quality low (Edwards, J Am Podiatr Med Assoc 2021). Expectations should be set against the ceiling: pooling 2,998 patients, complete pain relief followed injection in 43 per cent (95% CI 23 to 64) against 74 per cent (66 to 82) after surgical excision, and 15 per cent of injected patients went on to surgery (Lu, Acta Neurochir 2020).

Pairing reviewed 2026-09-10.

Where it fits for you

A reasonable first step before considering surgery, with footwear and forefoot loading addressed alongside. Repeated corticosteroid into the web space is not the plan — see the note on cortisone.

Read more about ultrasound-guided injections
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible — no studies

What it involves

A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.

What the evidence shows

No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.

Pairing reviewed 2026-08-30.

Where it fits for you

A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.

Read more about v-actor vibration therapy

Energy-based treatment options

Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.

Radial or focused shockwave? Read the overview
Radial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. One small sham-controlled trial

What it involves

A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.

What the evidence shows

Unlike the other entrapments, the neuroma itself has been trialled, but the work is small, contested, and not specific to the radial device. Twenty-five people with more than eight months of failed conservative care were randomised to shockwave or sham: pain fell significantly in the treated group and not in the sham group over twelve weeks (Fridman, J Am Podiatr Med Assoc 2009). That result drew two published critiques of its analysis and reporting in the same journal (Payne; Turlik, J Am Podiatr Med Assoc 2009). A systematic review of 22 studies of non-operative treatment found shockwave produced a statistically significant improvement but with limits on where it applies, and recommended corticosteroid injection ahead of it (Thomson, Foot Ankle Surg 2019). A review of common foot and ankle conditions lists activity modification, orthoses and interdigital corticosteroid injection as first-line here and does not include shockwave (Cooper, JAMA 2023).

Pairing reviewed 2026-09-13.

Where it fits for you

The neuroma lies shallow enough for a radial device to reach it, so it is not implausible, but corticosteroid injection is the better-evidenced option and comes first. Worth raising only once injection has been tried or declined.

Read more about radial shockwave
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Plausible — no studies

What it involves

A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.

What the evidence shows

No trial evidence at this nerve. Carpal tunnel is the only entrapment with comparative shockwave data.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered only where an entrapment has not settled and the alternatives have been discussed.

Read more about focused shockwave (eswt)
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Plausible — no studies

What it involves

You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.

What the evidence shows

There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that we can point to. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative — a randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).

Pairing reviewed 2026-08-30.

Where it fits for you

Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why we describe it this way.

Read more about emtt

Biologic and joint injection options

Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.

Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Plausible — no studies

What it involves

Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.

What the evidence shows

No published randomised trial of platelet-rich plasma in Morton neuroma. The platelet-rich plasma literature is concentrated in tendon, joint and nerve-entrapment conditions, and a result at one site does not carry across to a different tissue and a different problem.

Pairing reviewed 2026-08-30.

Where it fits for you

Not offered for this. The carpal tunnel result does not transfer — a different nerve in a different tunnel is a different problem, and 5% glucose perineural injection is the better-evidenced option here in any case.

Read more about platelet-rich plasma (prp)
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not offered for this

What it involves

Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.

What the evidence shows

A search for dextrose or prolotherapy in Morton's and interdigital neuroma returned 11 records, and not one was a trial of either — one was about fungal infection between the toes cultured on dextrose agar. A review of injection treatment for chronic foot pain covers steroid, alcohol, capsaicin and hyaluronic acid for Morton's neuroma and does not include prolotherapy (Urits, Pain Ther 2020).

Pairing reviewed 2026-09-03.

Where it fits for you

Not offered for this. A Morton's neuroma is a thickened nerve between the toes, and the useful first steps are footwear width, a metatarsal dome and offloading rather than an injection aimed at ligament.

Read more about prolotherapy
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Second line to cortisone

What it involves

One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.

What the evidence shows

Unusually for a nerve problem, hyaluronic acid has been trialled here directly. Forty-four people with 48 affected feet were randomised to three weekly ultrasound-guided injections of either hyaluronic acid or triamcinolone: both groups improved in pain and AOFAS score out to twelve months, cortisone was clearly ahead at one, three and six months, and the two were no different by twelve. A quarter of the cortisone feet developed skin discolouration at the injection site while the hyaluronic acid group had no complications, and nobody in either group went on to have the neuroma removed (Ferreira, Bone Joint J 2024). A separate series of 83 people given the same three-injection course saw walking pain fall from 73 to 23 out of 100 and AOFAS rise from 32 to 87 at twelve months (Lee, Foot Ankle Int 2017). A systematic review of twelve injection studies in 1,438 people rates hyaluronic acid well tolerated but still under-researched (Millán-Silva, Pain Manag Nurs 2024). There is no placebo-controlled trial.

Pairing reviewed 2026-09-12.

Where it fits for you

Worth discussing where cortisone is unsuitable, has already been used repeatedly, or where skin thinning and discolouration at the injection site are a concern. Expect it to work more slowly than cortisone over the first six months, with the two evening out by a year.

Read more about viscosupplementation

Nerve-targeted options

Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.

Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Plausible — no studies

What it involves

Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.

What the evidence shows

No randomised trial at this nerve. The evidence sits at the median nerve in the carpal tunnel and the ulnar nerve at the elbow, where dextrose has repeatedly matched or beaten corticosteroid.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered on the same rationale where an entrapment has not settled, with the absence of direct trials stated.

Read more about lyftogt perineural therapy
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Plausible — no studies

What it involves

Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.

What the evidence shows

No randomised trial at this nerve. The evidence sits at the median nerve in the carpal tunnel and the ulnar nerve at the elbow, where dextrose has repeatedly matched or beaten corticosteroid.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered on the same rationale where an entrapment has not settled, with the absence of direct trials stated.

Read more about ultrasound-guided nerve hydrodissection

This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.

Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target.

A note on cortisone

Corticosteroid injection is reviewed separately for each diagnosis.

Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.

So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.

When we would still consider it

  • Pain severe enough to block rehabilitation
  • A clear inflammatory or bursal target on imaging
  • A specific short-term goal — a trip, a procedure, a return to work
  • Diagnostic use, where the response tells us where the pain is coming from

When a cortisone injection is worth doing, and when it is not

Other foot, ankle & lower leg conditions

Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.

Frequently asked questions

Is Morton neuroma actually a tumour?
No. It is usually thickening or irritation around an interdigital nerve rather than a true tumour. Intermetatarsal bursitis can cause similar symptoms.
What helps forefoot nerve pain?
Wider footwear, metatarsal pads, activity changes and addressing load can help. Ultrasound-guided injection may be considered when symptoms persist.
Is imaging useful?
Ultrasound can help distinguish neuroma, bursitis and other forefoot problems, especially when symptoms are persistent or an injection is being considered.

Ready for a clearer plan for your back or musculoskeletal pain?

Book an assessment with Dr Joshua Hatch.

Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.

Book an appointment
Book an appointment with Back Pain Doctor
Book now Call